Clinical Features and Outcomes of Patients With Human Immunodeficiency Virus With COVID-19

Cristina Gervasoni; Paola Meraviglia; Agostino Riva; Andrea Giacomelli; Letizia Oreni; Davide Minisci; Chiara Atzori; Annalisa Ridolfo; Dario Cattaneo

doi:10.1093/cid/ciaa579

Clinical Features and Outcomes of Patients With Human Immunodeficiency Virus With COVID-19

Clin Infect Dis. 2020 Nov 19;71(16):2276-2278. doi: 10.1093/cid/ciaa579.

Authors

Affiliations

¹ Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.
² Gestione Ambulatoriale Politerapie (GAP) Outpatient Clinic, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.
³ Unit of Clinical Pharmacology, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.

Abstract

Little is known about the clinical outcomes of patients with human immunodeficiency virus infected with SARS-CoV-2. We describe 47 patients referred to our hospital between 21 February and 16 April 2020 with proven/probable COVID-19, 45 (96%) of whom fully recovered and 2 who died.

Keywords: COVID-19; HIV; SARS-CoV-2; observational study; real-life.

Publication types

Observational Study

MeSH terms

Adult
Antiviral Agents / therapeutic use
COVID-19 / complications*
COVID-19 Drug Treatment
Female
HIV Infections / complications*
Hospitalization
Humans
Italy
Male
Middle Aged
Prognosis
Retrospective Studies
Risk Factors
SARS-CoV-2

Substances

Antiviral Agents